摘要
药品分类管理作为国际上普遍认可并采用的管理模式,在我国于2000年1月1日正式实施。其中,药品“双跨”管理作为药品分类管理中的一种特殊管理模式,在国内外广泛存在。文章通过梳理分析我国、美国、英国和日本的药品分类管理情况,结合当前我国药品分类管理具体情况,提出几点思考,以期为我国进一步完善药品分类管理制度提供参考。
As a widely recognized and adopted management model internationally,drug classification management was officially implemented in China on January 1st,2000."Double Classification"management of drugs,as a special management mode in drug classification management,widely existed at home and abroad.This article analyzed the situation of drug classification management in China,the USA,the U.K.and Japan,and proposed several considerations based on the current specific situation of drug classification management in China,with a view to providing reference for further improving the drug classification management system in China.
作者
于冬梅
于洪礼
Dong-Mei YU;Hong-Li YU(Center for Food Evaluation,State Administration for Market Regulation/National Committee on the Assessment of the Protected Traditional Chinese Medicinal Products,Beijing 100070,China;Center for Drug Reevaluation,NMPA/NMPA Key Laboratory for Research and Evaluation of Pharmacovigilance,Beijing 100022,China)
出处
《药物流行病学杂志》
CAS
2023年第6期698-701,共4页
Chinese Journal of Pharmacoepidemiology
关键词
药品
双跨
分类管理
Drug
Double classification
Classification management